Nektar Therapeutics PE Ratio 2006-2019 | NKTR

Current and historical p/e ratio for Nektar Therapeutics (NKTR) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nektar Therapeutics PE ratio as of August 16, 2019 is 0.00.
Nektar Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-08-16 18.10 0.00
2019-06-30 35.58 $-2.44 0.00
2019-03-31 33.60 $3.52 9.55
2018-12-31 32.87 $3.60 9.13
2018-09-30 60.96 $3.96 15.39
2018-06-30 48.83 $4.89 9.99
2018-03-31 106.26 $-0.83 0.00
2017-12-31 59.72 $-0.65 0.00
2017-09-30 24.00 $-0.72 0.00
2017-06-30 19.55 $-1.41 0.00
2017-03-31 23.47 $-1.38 0.00
2016-12-31 12.27 $-1.10 0.00
2016-09-30 17.18 $-1.22 0.00
2016-06-30 14.23 $-0.96 0.00
2016-03-31 13.75 $-1.00 0.00
2015-12-31 16.85 $-0.61 0.00
2015-09-30 10.96 $-0.56 0.00
2015-06-30 12.51 $0.03 417.00
2015-03-31 11.00 $0.17 64.71
2014-12-31 15.50 $-0.45 0.00
2014-09-30 12.07 $-0.51 0.00
2014-06-30 12.82 $-1.18 0.00
2014-03-31 12.12 $-1.29 0.00
2013-12-31 11.35 $-1.40 0.00
2013-09-30 10.45 $-1.45 0.00
2013-06-30 11.55 $-1.69 0.00
2013-03-31 11.00 $-1.62 0.00
2012-12-31 7.41 $-1.50 0.00
2012-09-30 10.68 $-1.37 0.00
2012-06-30 8.07 $-1.20 0.00
2012-03-31 7.92 $-1.22 0.00
2011-12-31 5.60 $-1.19 0.00
2011-09-30 4.85 $-1.10 0.00
2011-06-30 7.27 $-0.98 0.00
2011-03-31 9.47 $-0.67 0.00
2010-12-31 12.85 $-0.41 0.00
2010-09-30 14.77 $-0.25 0.00
2010-06-30 12.10 $-0.49 0.00
2010-03-31 15.21 $-0.83 0.00
2009-12-31 9.32 $-1.10 0.00
2009-09-30 9.74 $-0.19 0.00
2009-06-30 6.48 $-0.26 0.00
2009-03-31 5.39 $-0.27 0.00
2008-12-31 5.56 $-0.37 0.00
2008-09-30 3.59 $-0.78 0.00
2008-06-30 3.35 $-0.58 0.00
2008-03-31 6.94 $-0.52 0.00
2007-12-31 6.71 $-0.36 0.00
2007-09-30 8.83 $-1.21 0.00
2007-06-30 9.49 $-1.23 0.00
2007-03-31 13.06 $-1.63 0.00
2006-12-31 15.21 $-1.73 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.188B $1.193B
Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to meet unmet medical needs and improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain. In the area of pain, Nektar has a worldwide license agreement with AstraZeneca for NKTR-118, an investigational drug candidate, being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation. The agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of NKTR-118 and an opioid. Also in the area of pain, NKTR-181, the company's wholly-owned novel mu-opioid analgesic molecule, is being evaluated in Phase 1 clinical studies. Nektar Therapeutics is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.064B 36.38
Takeda Pharmaceutical (TAK) Japan $26.341B 8.22
Astellas Pharma (ALPMY) Japan $26.215B 12.85
UCB SA (UCBJF) Belgium $15.008B 0.00
Grifols, S.A (GRFS) Spain $15.002B 19.14
Eisai (ESALY) Japan $14.332B 24.64
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.481B 20.45
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.689B 0.00
IPSEN SA ADR (IPSEY) France $8.520B 0.00
Sage Therapeutics (SAGE) United States $8.318B 0.00
Catalent (CTLT) United States $8.054B 32.32
Jazz Pharmaceuticals (JAZZ) Ireland $7.439B 9.79
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.735B 17.02
FibroGen (FGEN) United States $3.750B 93.78
United Therapeutics (UTHR) United States $3.487B 0.00
Tilray (TLRY) Canada $3.415B 0.00
Evotec AG (EVTCY) Germany $3.120B 42.71
Taro Pharmaceutical Industries (TARO) Israel $3.103B 11.12
Arrowhead Pharmaceuticals (ARWR) United States $2.767B 63.44
PTC Therapeutics (PTCT) United States $2.614B 0.00
Xencor (XNCR) United States $2.284B 49.79
Portola Pharmaceuticals (PTLA) United States $2.085B 0.00
Zogenix (ZGNX) United States $2.057B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.621B 59.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.452B 14.56
Corcept Therapeutics (CORT) United States $1.439B 19.78
Ironwood Pharmaceuticals (IRWD) United States $1.404B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.384B 22.84
Heron Therapeutics (HRTX) United States $1.349B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.205B 0.00
Aerie Pharmaceuticals (AERI) United States $1.129B 0.00
Radius Health (RDUS) United States $1.040B 0.00
ArQule (ARQL) United States $1.039B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.837B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.718B 3.20
TherapeuticsMD (TXMD) United States $0.716B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.552B 0.00
Karyopharm Therapeutics (KPTI) United States $0.545B 0.00
Concordia (CXRXF) Canada $0.533B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.518B 0.00
Akebia Therapeutics (AKBA) United States $0.511B 0.00
Endo (ENDP) Ireland $0.505B 0.89
Aptorum Group (APM) China $0.477B 0.00
Indivior (INVVY) United States $0.466B 1.68
Crinetics Pharmaceuticals (CRNX) United States $0.437B 0.00
Dermira (DERM) United States $0.430B 0.00
Dova Pharmaceuticals (DOVA) United States $0.427B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.421B 19.12
ImmunoGen (IMGN) United States $0.412B 0.00
Siga Technologies (SIGA) United States $0.411B 0.96
Flexion Therapeutics (FLXN) United States $0.409B 0.00
Translate Bio (TBIO) United States $0.405B 0.00
ChemoCentryx (CCXI) United States $0.376B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Collegium Pharmaceutical (COLL) United States $0.366B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.354B 0.00
Organogenesis Holdings (ORGO) United States $0.326B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.322B 0.00
CV Sciences (CVSI) United States $0.317B 0.00
Xeris Pharmaceuticals (XERS) United States $0.292B 0.00
Harpoon Therapeutics (HARP) United States $0.286B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.285B 0.00
CannTrust Holdings (CTST) Canada $0.280B 0.00
KalVista Pharmaceuticals (KALV) United States $0.280B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.256B 0.00
Lannett Co Inc (LCI) United States $0.255B 2.48
DURECT (DRRX) United States $0.250B 0.00
OptiNose (OPTN) United States $0.249B 0.00
Concert Pharmaceuticals (CNCE) United States $0.244B 0.00
Recro Pharma (REPH) United States $0.241B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.219B 0.00
Calithera Biosciences (CALA) United States $0.210B 0.00
Ocular Therapeutix (OCUL) United States $0.199B 0.00
Molecular Templates (MTEM) United States $0.186B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.176B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 29.03
Redhill Biopharma (RDHL) Israel $0.147B 0.00
IMV INC (IMV) Canada $0.140B 0.00
Ardelyx (ARDX) United States $0.135B 0.00
GlycoMimetics (GLYC) United States $0.132B 0.00
Jounce Therapeutics (JNCE) United States $0.130B 0.00
Generex Biotechnology (GNBT) United States $0.128B 0.00
Majesco Entertainment (PTE) United States $0.119B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.107B 0.00
MEI Pharma (MEIP) United States $0.106B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.104B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.098B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.092B 0.00
Aquestive Therapeutics (AQST) United States $0.088B 0.00
Neos Therapeutics (NEOS) United States $0.088B 0.00
Cardiome Pharma (CORV) Canada $0.085B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 32.41
Genocea Biosciences (GNCA) United States $0.082B 0.00
Natural Alternatives (NAII) United States $0.076B 7.62
RENEURON GP (RNUGF) United Kingdom $0.075B 0.00
MediWound (MDWD) Israel $0.074B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.074B 0.00
Nivalis Therapeutics (ALPN) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 598.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
China SXT Pharmaceuticals (SXTC) China $0.068B 0.00
Otonomy (OTIC) United States $0.067B 0.00
Novan (NOVN) United States $0.065B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.063B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
Capnia (SLNO) United States $0.057B 0.00
Lipocine (LPCN) United States $0.053B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
CTI BioPharma (CTIC) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Aclaris Therapeutics (ACRS) United States $0.033B 0.00
Melinta Therapeutics (MLNT) United States $0.032B 0.00
PharmAthene (ALT) United States $0.032B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.43
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.002B 0.00
Xenetic Biosciences (XBIO) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00